US FDA approves J&J's bladder cancer treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. DELL
4. MDB
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. USO
10. SNOW

Go back to US FDA approves J&J's bladder cancer treatment
Johnson & Johnson (NYSE: JNJ) Delayed: 275.21 +4.02 (1.48%)
Previous Close $271.19    52 Week High $126.07 
Open $274.74    52 Week Low $94.28 
Day High $281.07    P/E 57.22 
Day Low $273.53    EPS $4.81 
Volume 7,912,744